Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

212 trials

NCT07455578
Recruiting
Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
Phase 1 · Australia · 2 sites
Registry update: 1 Jun 2026
NCT07648602
Recruiting
PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
Not applicable · United States · 1 site
Registry update: 26 Aug 2026
NCT07582783
Recruiting
A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
Not applicable · Romania · 20 sites
Registry update: 3 Nov 2026
NCT07546032
Recruiting
Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy
Not applicable · Italy · 1 site
Registry update: 28 Jul 2026
2026-525575-22-00
Recruiting
A first in human study of the safety, pharmacokinetics and pharmacodynamics of KLR-003 in healthy participants and patients with immune mediated diseases.
Phase 1 · Netherlands · 1 site
Registry update: 23 Oct 2026
NCT07111494
Recruiting
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
Phase 4 · United States · 1 site
Registry update: 5 Nov 2026
NCT07545902
Recruiting
Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
Not applicable · Italy · 1 site
Registry update: 28 Jul 2026
NCT07611747
Recruiting
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Phase 4 · Spain · 17 sites
Registry update: 28 May 2026
NCT07529236
Recruiting
Digestive Evolution of Children With Crohn's Disease or Ulcerative Colitis Whose Anti-TNFα Treatment Was Switched to Ustekinumab Due to Paradoxical Psoriasis,
Not applicable · France · 1 site
Registry update: 25 Jun 2026
NCT07532226
Recruiting
A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants
Not applicable · France · 1 site
Registry update: 3 Nov 2026
NCT07352306
Recruiting
Topical Diacerein in Psoriasis Vulgaris
Phase 4 · Egypt · 1 site
Registry update: 22 Oct 2026
NCT07672561
Recruiting
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase Ⅲ Study to Evaluate the Efficacy and Safety of WD-890 Tablets for the Treatment of Moderate to Severe Plaque Psoriasis
Phase 3 · China · 1 site
Registry update: 29 Jun 2026
NCT07087912
Recruiting
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Phase 4 · Brazil · 2 sites
Registry update: 20 Jul 2026
NCT07486843
Recruiting
Preventing Structural Damage in Early Psoriatic Arthritis
Phase 4 · Hong Kong · 1 site
Registry update: 23 Mar 2026
NCT07286058
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Phase 3 · Australia, Belgium, Bulgaria, China, Czechia, Germany, Estonia, Spain, France, Croatia, Hungary, Israel, Italy, Japan, Latvia, New Zealand, Poland, Puerto Rico, Portugal, Taiwan, United States · 163 sites
Registry update: 9 Sept 2026
NCT07443956
Recruiting
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Not applicable · United Kingdom · 4 sites
Registry update: 4 May 2026
NCT07471048
Recruiting
A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Not applicable · United States · 1 site
Registry update: 13 Mar 2026
NCT06702293
Recruiting
Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients
Not applicable · Singapore · 1 site
Registry update: 28 Sept 2026
NCT07449702
Recruiting
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Phase 2 · Canada, Germany, Spain, United States · 42 sites
Registry update: 23 Oct 2026
NCT07362017
Recruiting
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Phase 3 · United States · 10 sites
Registry update: 22 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.